COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 176 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $28,842,586 | +5.9% | 1,290,496 | +1.8% | 0.00% | +100.0% |
Q2 2023 | $27,237,909 | -16.1% | 1,267,469 | -6.3% | 0.00% | -50.0% |
Q1 2023 | $32,451,081 | -45.7% | 1,352,692 | -47.5% | 0.00% | 0.0% |
Q4 2022 | $59,773,130 | +173.8% | 2,576,428 | +89.1% | 0.00% | +100.0% |
Q3 2022 | $21,830,000 | -11.4% | 1,362,662 | -2.0% | 0.00% | 0.0% |
Q2 2022 | $24,643,000 | -7.5% | 1,390,693 | +6.3% | 0.00% | 0.0% |
Q1 2022 | $26,634,000 | +24.7% | 1,308,167 | +14.4% | 0.00% | 0.0% |
Q4 2021 | $21,352,000 | -6.1% | 1,143,023 | -0.8% | 0.00% | 0.0% |
Q3 2021 | $22,734,000 | -16.7% | 1,151,662 | -0.2% | 0.00% | 0.0% |
Q2 2021 | $27,291,000 | +5.0% | 1,154,423 | +5.3% | 0.00% | 0.0% |
Q1 2021 | $25,980,000 | +69.9% | 1,096,202 | +43.6% | 0.00% | 0.0% |
Q4 2020 | $15,292,000 | -2.4% | 763,468 | +1.4% | 0.00% | 0.0% |
Q3 2020 | $15,668,000 | +9.8% | 752,561 | -7.7% | 0.00% | 0.0% |
Q2 2020 | $14,265,000 | +23.1% | 815,143 | +14.8% | 0.00% | 0.0% |
Q1 2020 | $11,591,000 | -22.3% | 709,806 | -2.1% | 0.00% | 0.0% |
Q4 2019 | $14,924,000 | +86.8% | 725,163 | +4.2% | 0.00% | 0.0% |
Q3 2019 | $7,991,000 | -10.2% | 696,037 | +2.9% | 0.00% | 0.0% |
Q2 2019 | $8,894,000 | -9.1% | 676,316 | +4.7% | 0.00% | 0.0% |
Q1 2019 | $9,783,000 | -10.6% | 646,167 | +1.3% | 0.00% | 0.0% |
Q4 2018 | $10,948,000 | -5.1% | 637,612 | -18.5% | 0.00% | 0.0% |
Q3 2018 | $11,536,000 | -25.8% | 782,595 | +20.0% | 0.00% | 0.0% |
Q2 2018 | $15,551,000 | -0.0% | 651,916 | +7.1% | 0.00% | 0.0% |
Q1 2018 | $15,552,000 | +132.8% | 608,575 | +68.3% | 0.00% | 0.0% |
Q4 2017 | $6,679,000 | +96.6% | 361,622 | +11.5% | 0.00% | – |
Q3 2017 | $3,398,000 | -15.6% | 324,466 | +1.0% | 0.00% | – |
Q2 2017 | $4,025,000 | +46.5% | 321,340 | +17.7% | 0.00% | – |
Q1 2017 | $2,748,000 | -39.3% | 273,104 | -5.6% | 0.00% | – |
Q4 2016 | $4,530,000 | +18.7% | 289,219 | +46.1% | 0.00% | – |
Q3 2016 | $3,815,000 | +81.9% | 197,932 | +11.8% | 0.00% | – |
Q2 2016 | $2,097,000 | +4.4% | 176,997 | +60.1% | 0.00% | – |
Q1 2016 | $2,009,000 | -3.9% | 110,573 | +45.7% | 0.00% | – |
Q4 2015 | $2,090,000 | +32.5% | 75,865 | +6.2% | 0.00% | – |
Q3 2015 | $1,577,000 | +98.6% | 71,430 | +60.5% | 0.00% | – |
Q2 2015 | $794,000 | – | 44,506 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Rubric Capital Management LP | 2,606,500 | $51,452,000 | 1.44% |
Camber Capital Management LP | 2,000,000 | $39,480,000 | 1.22% |
Eventide Asset Management | 2,629,593 | $51,908,000 | 0.68% |
GREAT POINT PARTNERS LLC | 121,342 | $2,395,000 | 0.56% |
RICE HALL JAMES & ASSOCIATES, LLC | 753,038 | $14,865,000 | 0.55% |
Values First Advisors, Inc. | 41,773 | $825,000 | 0.53% |
CLARK ESTATES INC/NY | 183,800 | $3,628,000 | 0.52% |
EMERALD MUTUAL FUND ADVISERS TRUST | 710,398 | $14,023,000 | 0.48% |
EMERALD ADVISERS, LLC | 590,256 | $11,652,000 | 0.42% |
ACORN FINANCIAL ADVISORY SERVICES INC /ADV | 68,812 | $1,358,000 | 0.42% |